Updates on the Classification, Diagnosis, and Treatment of ​Urinary Tract Infections (UTIs) in Adults

About

Urinary tract infections (UTIs) remain among the most common bacterial infections encountered by physicians, leading to frequent outpatient visits, hospital admissions, and recurrent episodes in certain groups. They affect all ages but occur more often in women, the elderly, and individuals with comorbidities or urological abnormalities. Because of their prevalence, varied presentations, and potential for complications, UTIs continue to represent an important area of clinical practice requiring clear diagnostic and management strategies.

Recent updates in international guidelines, specifically the EAU new classification of UTI, propose a simpler classification, distinguishing UTI as localized—with symptoms limited to the urinary tract—or systemic, where infection is associated with systemic signs. This approach avoids the ambiguity of the older “uncomplicated vs complicated” terminology. The clinical spectrum ranges from mild cystitis to severe pyelonephritis or urosepsis. Common symptoms include dysuria, frequency, urgency, and suprapubic pain, while systemic involvement may present with fever, flank pain, or sepsis. Diagnosis is often clinical but supported by urinalysis and culture when confirmation is needed or in recurrent and severe cases.

Antibiotic therapy remains the cornerstone of treatment, with choice guided by infection severity, local resistance patterns, and stewardship considerations. Narrow-spectrum or short-course regimens are appropriate for localized lower tract infections, while broader coverage and sometimes parenteral therapy are needed for systemic infections. Effective management balances timely treatment with the responsibility to minimize antimicrobial resistance.

Prevention strategies range from lifestyle modifications to selective use of prophylactic measures in patients with recurrent infections. Non-antibiotic options, including topical estrogen in postmenopausal women, cranberry extracts, D-mannose, and immunoactive agents, have shown benefit in certain groups. Antibiotic prophylaxis is reserved for carefully selected patients with recurrent UTIs that significantly impair quality of life. Ultimately, a structured approach to classification, diagnosis, and individualized treatment of urinary tract infections supports both patient outcomes and long-term public health goals.

By the end of this learning activity, physicians will be equipped with a clear and practical overview of current concepts in UTI diagnosis and management. By focusing on updated classification, evidence-based diagnostic approaches, appropriate antimicrobial use, and strategies for prevention, this module aims to enhance clinical decision-making while promoting patient safety and antimicrobial stewardship.